Trace Biosciences
UEI: YGDTEJXJC9G8
• CAGE: 9HEB7
Overview
Awardee Type
Parent
Company Description
Eliminating surgical nerve damage using the power of imaging. Trace Biosciences is developing nerve-specific fluorescence contrast agents for real-time, intraoperative nerve visualization.
Name
Trace Biosciences
Website
Headquarters
Beaverton, OR
United States
United States
Most Recent Award
Sept. 15, 2023
Calculating
Federal contract and grant recipient
TRACE BIOSCIENCES INC
(UEI YGDTEJXJC9G8, CAGE 9HEB7)
is headquartered in Beaverton OR.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in March 2019 and
federally registered in
January 2023.
Federal Award Analysis
Trace Biosciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
TRACE BIOSCIENCES INC
UEI
YGDTEJXJC9G8
CAGE Code
9HEB7
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
March 20, 2019
Initial Registration
Jan. 10, 2023
Last Registration
Nov. 7, 2024
Registration Activation
Nov. 7, 2024
Registration Expiration
Nov. 5, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No